Objectives: This study was done to determine the drug resistance pattern and Extended Spectrum β-Lactamase (ESBL) in bacterial isolates of Enterobacteriaceae family from different clinical specimens.
INTRODUCTION
The prevalence of multidrug resistance (MDR) bacterial species has increased considerably since the introduction followed by arbitrary use of new generation extended spectrum antibiotics like third and fourth generation cephalosporins, carbapenems, monobactams, broad and extended spectrum penicillins and other antibiotics (Fang et al. 2008 ).
Multidrug resistance bacterial isolates have been frequently reported from different parts of the world as an emergence of treatment problem. The World Health Organization (WHO), the European Commission (EU), and the U.S. Centers for Disease Control and Prevention (CDC) have recognized the importance of studying the emergence and determinants of multidrug resistance as well as the need for control (Alekshum 2007) . Citrobacter, Enterobacter, Escherichia, Klebsiella, Proteus, Salmonella, Serratia, Shigella, Yersinia, etc. are the medically important genera of the family Enterobacteriaceae (Gray 1995) .
Extended spectrum β-lactamases (ESBLs) in
Enterobacteriaceae is defi ned as β-lactamases capable of hydrolyzing penicillins, broad and extendedspectrum cephalosporins and monobactams and are inhibited by clavulanic acid. They are generally derived from TEM and SHV-type enzymes. ESBLs are often located on plasmids that are transferable from strain to strain and between bacterial species. ESBLsproducing Enterobacteriaceae have been responsible for numerous outbreaks of infection throughout the world and pose challenging infection control issues (Rupp and Fey 2003) .
Antibiotic resistance is one of the alarming issues, affecting human health. There are various factors responsible to the emergence of resistance such as misuse and overuse of antibiotics, patients related factors, inappropriate prescriptions by physicians, self-medications especially young adults, use of broad TUJM VOL. 4, NO. 1, 2017 spectrum antibiotics and synergistic combinations, unnecessary promotion by pharmaceutical industry, and lack of awareness with the new guidelines recommended for antimicrobial testing, etc. Multidrug resistance is getting common phenomenon and are being reported worldwide (Khan et al. 2014 ).
Multidrug Resistance among bacteria is one of the greatest challenges in the fi eld of medicine. Resistance mechanism to different classes of antibiotics such as tetracyclines, aminoglycosides and cotrimoxazole is of bigger issue. However, broad spectrum resistance to β-lactam and fl uoroquinolones are of utmost signifi cance. In the early 1950s, enteric bacteria that mediated resistance to fi rst penicillin attracted attention of the researchers. The introduction of 3 rd generation cephalosporins was milestone in antimicrobial chemotherapy but after few years resistance to these drugs was observed in different species (Sanders and Sanders 1987) . 
MATERIALS AND METHODS
Study population: A prospective cross-sectional study was performed for 6 months (14/10/2015 to 13/04/2016) at National Medical College and Teaching
Hospital, Birgunj. This study included patients of all age group and both sexes visiting this hospital from whom samples were sent for routine culture and antibiotic susceptibility testing.
Conventional microbiological tests:
The identifi cation of various gram negative isolates was done using 
RESULTS
A total of 1602 clinical specimen were investigated during a six-month study period, of which 877 (54.7%) and 725 (45.3%) were from female and male patients respectively. Among 1602 specimens, 1192 (74.4%)
were from indoor patients and 410 (25.6%) specimens from outdoor patients were included in the study.
Distribution of total clinical specimens under investigation
Among the total 1602 clinical specimens analyzed, 649
(40.5%) were urine, 360 (22.5%) were pus, 329 (20.5%)
were blood, 169 (10.5%) were sputum, 84 (5.2%) were body fl uids, 6 (0.4%) were stool and 5 (0.3%) were ET tip and secretion specimens. 
MDR Enterobacteriaceae isolates in different clinical specimens
Out of total 200 isolates, 171 (85.5%) isolates were multidrug resistant among which all the isolates from sputum and stool specimens showed 100% multidrug resistance while blood specimens showed 93.3% MDR followed by urine (84.1%), and pus (81.5%). (Table   7) . Of the total 200 isolates of Enterobacteriaceae, E. TUJM 4(1): 15-22 TUJM VOL. 4, NO. 1, 2017 coli was the the predominant pathogen with 56.5% which was comparable with the result of Mulla (2012) i.e, 55.6%. Ghimire (2016) reported 53.8% but high prevalence i.e, 73.4% of E. coli reported by Panta (2012) in the similar study. Following E. coli, K. pneumoniae was found to be the most frequently isolated bacteria with 31.5% which was comparable with the result of Mulla (2012) i.e, 31.2%. Ghimire (2016) reported 34.6%
DISCUSSION
but very low prevalence of K. pneumoniae was reported by Panta (2012) in the similar study. In comparison of 4% of Proteus species isolated by Mangaiarkkarasi et al. (2013), 5.5% of P. mirabilis and 3.5% P. vulgaris were isolated in our study. But higher prevalence of Enterobacter (7.9%) was found in the study of Mulla used against all the isolates of Enterobacteriaceae , imipenem (89.5%) was found to be the most effective antibiotic followed by amikacin (73%) which was in accordance with the similar study conducted by Ghimire (2016) . Nitrofurantoin was found to be 77.9%
sensitive among urinary Enterobacteriaceae isolates.
Similarly in a study antibiotic sensitivity pattern of the isolates revealed that 89.5% of the isolates were sensitive to imipenem, 73% were sensitive to amikacin followed by chloramphenicol (69.5%), and tetracycline (52.5%) whereas high resistance was seen for ampicillin (98.5%), cefi xime (80.5%), amoxyclav (77.5%), ceftriaxone (73.55%), cefotaxime (72%), cefoxitin (65%), cotrimoxazole (58%) and ciprofl oxacin (58%) (Metri et al. 2011) .
In this study a total of 200 isolates of Enterobacteriaceae were isolated from 1602 different clinical specimens processed. Thus, the prevalence of Enterobacteriaceae in various clinical specimens was found to be 12.5%.
Of the total isolates of Enterobacteriaceae, 171 (85.5%) were found to be multidrug resistant. Similar study conducted in Sahid Gangalal Memorial Hospital by Ghimire (2016) showed 11.8% growth and 82.6% of them were MDR. In a study by Yadav (2015) showed high growth positivity of 31.3% and 96.8% multidrug resistance among them. Another study conducted by Panta (2012) (Patridge 2015) .
The high level of drug resistance seen among E. coli is mediated by beta-lactamases, which hydrolyzes the beta-lactam ring inactivating the antibiotic. The classical TEM-1, TEM-2 and SHV-1 enzymes are the predominant plasmid-mediated beta-lactames of Gram negative rods (Livermore 1995) . Mutations at the target site i.e, gyrA, which is a gyrase subunit gene, and parC, which encodes a topoisomerase subunit, confer resistance to fl uoroquinolones (Ozeki et al. 1997 ). In addition to this mechanism, there are more than effl ux systems in E. coli that can export structurally unrelated antibiotics; these multidrug resistance effl ux pump (MDR pump) systems contribute to intrinsic resistance for toxic compounds such as antibiotics, antiseptics, detergents and dyes (Sulavik et al. 2001 ).
Higher level of drug resistance seen in K. pneumoniae There are many mechanisms whereby Proteus spp.
confer resistance to the drugs including impermeability and acquired resistance ass plasmids, transposons and mutations (Paudel 2013) . However, the production of plasmid or chromosomal encoded beta-lactamase enzyme is the most common mechanism of resistance in Gram negative bacteria causing clinical signifi cant infection (Bush et al. 1995) . TUJM 4(1): 15-22 VOL. 4, NO. 1, 2017 Of the total MDR Enterobacteriaceae isolates tested Enterobacter spp. resistance to oxyimino-cephalosporin is due to mutational hyper production of chromosomal AmpC beta-lactamase production rather than ESBL (Beceiro et al. 2008; Livermore and Brown 2001) .
